Abstract
This patent describes novel substituted benzisoxazole sulfonamides as lysine acetyl transferase (KAT) inhibitors with potential applications in cancer therapy. It provides details on the synthesis of novel substituted benzisoxazole sulfonamides, their pharmaceutical composition, and the use in the treatment of cancers.